Clinical evaluation of Ahmed glaucoma valve implantation for uncontrolled primary congenital glaucoma
10.3980/j.issn.1672-5123.2015.5.40
- VernacularTitle:Ahmed青光眼引流阀植入治疗先天性青光眼术后眼压失控疗效分析
- Author:
Wen-Sheng, LU
;
Xiao-Bing, WANG
;
Dong, HAN
;
Cui-Xia, HAO
;
Ning-Zhou, GAO
;
Shao-Hui, YANG
;
Jian-Hua, LV
- Publication Type:Journal Article
- Keywords:
Ahmed glaucoma valve implantation;
primary congenital glaucoma;
uncontrolled intraocular pressure
- From:
International Eye Science
2015;(5):890-891
- CountryChina
- Language:Chinese
-
Abstract:
?AlM: To investigate the outcome and safety of Ahmed glaucoma valve implantation treatment in uncontrolled primary congenital glaucoma ( PCG) .
? METHODS: Twenty - two eyes in 22 children with uncontrolled PCG were reviewed retrospectively and underwent Ahmed glaucoma valve implantation treatment from January 2011 to December 2014. Main checking index included intraocular pressure ( lOP ) before and after operation, corneal diameter and complications.
?RESULTS: Preoperative mean age was 3. 74±2. 24y, and 2. 59 ± 1. 78y apart from the last operation. Postoperative average lOP was 35. 22 ± 6. 36mmHg. Average corneal diameter was 12. 79 ± 0. 75mm. Mitomycin C ( 0. 3 - 0. 5mg/mL ) was used in all operations for 3-5min. Glaucoma valves were implanted in the temporal or nose above the equator sclera. Postoperative lOP was 11. 4±4. 45mmHg at 1wk, and 16. 73± 7. 23mmHg after 12mo. As lOP< 21mmHg for success criteria, lOP of 16 eyes ( 73%) were controlled after 12mo. Preoperative 6 cases had shallow anterior chamber, recovered spontaneously. No serious complication was recorded, such as rejection of glaucoma valve, endoophthalmitis and corneal decompensation.
?CONCLUSlON:Ahmed glaucoma valve implantation in uncontrolled PCG is a safe and viable treatment.
